Navigation Links
DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two million Americans are affected each year by DVT, with up to 600,000 hospitalized. Its primary complication, pulmonary embolism (PE), claims up to 300,000 lives annually -- more than breast cancer and AIDS combined. People who suffer from cardiovascular disease may be at increased risk for DVT, because these factors also heighten the likelihood of blood clots and pooling. Respiratory tract infection may increase risk of blood clots and is associated with inflammation, which may affect the proper functioning of arteries and veins.

The Coalition to Prevent Deep-Vein Thrombosis (DVT) recently sponsored an online survey of a nationally representative sample of consumers and physicians. The survey, which was conducted by Penn, Schoen & Berland Associates, assessed what Americans know about DVT.

The survey results point to an ongoing need for patients and physicians alike to know more about this leading cause of death and how they can reduce the risk of DVT. Following are the results specific to respiratory disease.

    Heart/respiratory patients recognize the significance of heart disease as

    a risk factor for DVT but incorrectly view pulmonary/respiratory disease

    as a much less significant threat.

       * 60% of heart/respiratory patients rate cardiac issues (e.g., heart

         disease, heart attack, arteriosclerosis or CHF) as very significant

         risk factors for DVT.

       * Only 35% see pulmonary/respiratory disease (e.g., asthma, COPD or

         emphysema) as a very significant risk factor.


    Even though they are at greater risk for DVT, heart/respiratory patients

    know only as much about it as the general population.

       * 52% of heart/respiratory patients have some knowledge about DVT -- on

         par with the general population (51%).

       * 40% of heart/respiratory patients have heard or read about DVT

         recently, the same percent
age as in the general population.


    Heart/respiratory patients who know something about DVT are no more likely

    than the general population to recognize key facts about the condition.

       * 17% of heart/respiratory patients correctly identify DVT as a blood

         clot, the same percentage as in the general population.

       * 17% recognize that DVT is a dangerous condition, one that can cause

         stroke or heart attack, or one that can be fatal.


    Despite their greater risk, heart/respiratory patients are no more likely

    than the general population to have discussed DVT with their physicians.

       * 10% of heart/respiratory patients report that their primary care

         physician has discussed DVT with them, compared with 12% of the

         general population.

       * 55% of heart/respiratory patients say that they are likely to ask

         their physicians for DVT information, vs. 50% of the general

         population.

The Coalition to Prevent Deep-Vein Thrombosis is funded by sanofi-aventis U.S. LLC

US.ENO.07.01.122

CONTACT: Shannon McIntyre, +1-212-614-4351

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Survey Reveals Significant Public Lack of Diabetes Awareness
2. DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
5. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
8. New Survey Finds Troubling Data on American Asthma Sufferers
9. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/18/2017)... SAN DIEGO and BLOOMINGTON, ... Pharmaceuticals, Inc. (NASDAQ: IMMY ) ("Imprimis"), ... d/b/a Precision Lens ("Precision Lens"), today announced the ... Under the agreement, Precision Lens will deploy a ... into select geographies in the U.S., primarily focused ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
Breaking Medicine News(10 mins):